Oticon Ending Supply Arrangement with One Source Hearing
No disruption to existing services for Oticon customers is expected.
No disruption to existing services for Oticon customers is expected.
SENS-501 is a gene therapy candidate being developed to treat a form of congenital deafness linked to mutations in the OTOF (otoferlin) gene.
Federal funding cuts to hearing health programs and research threaten innovation, access, and outcomes in audiology care, with especially dire consequences for vulnerable populations and early childhood intervention.
Starkey has been named a 2025 Top Workplace in Minnesota by the Star Tribune.
ACI Alliance is accepting abstract submissions for its upcoming clinical research conference, CI2026 Chicago: Conference on Cochlear Implants in Children and Adults.
A bipartisan group of U.S. senators has reintroduced the Medicare Audiology Access Improvement Act to eliminate barriers preventing Medicare beneficiaries from directly accessing care from audiologists.
Marshall Chasin fondly remembers Jack Katz, PhD, known for his pioneering work on central auditory processing disorders and improving audiology through research and education. He has died at the age of 91.
Researchers have restored hearing in mice with ENPP1 deficiency using a novel bone-targeted enzyme replacement therapy, offering hope for treating hearing loss in patients with this rare and often fatal genetic disorder.
Apprentices and students interested in a career in hearing care can participate in the entire EUHA 2025 event free of charge.